Skip to main content
Premium Trial:

Request an Annual Quote

U of Montreal To Use Sigma-Aldrich shRNA Library for RNAi Screening

NEW YORK (GenomeWeb News) - Sigma-Aldrich said today that it has signed an agreement to provide its RNAi technologies to the University of Montreal’s Institute of Research in Immunology and Cancer.
 
Under the agreement, the institute's high-throughput screening facility will have access to Sigma-Aldrich’s Mission RNAi IP portfolio and its shRNA library collection for human and mouse genomes.
 
Funding for the research was provided by Genome Quebec and by Sigma-Aldrich.
 
The company said it plans to use feedback from the studies to “further its understanding of specific target function” and to continue to develop its high-throughput drug research tools.